MJ, S., S, M., N, P., M, S., K, L., N, T., . . . CA, D. (2021). A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults. PloS one, 16(9), e0256980. https://doi.org/10.1371/journal.pone.0256980
Chicago Style (17th ed.) CitationMJ, Sklar, et al. "A Three-antigen Plasmodium Falciparum DNA Prime-Adenovirus Boost Malaria Vaccine Regimen Is Superior to a Two-antigen Regimen and Protects Against Controlled Human Malaria Infection in Healthy Malaria-naïve Adults." PloS One 16, no. 9 (2021): e0256980. https://doi.org/10.1371/journal.pone.0256980.
MLA (9th ed.) CitationMJ, Sklar, et al. "A Three-antigen Plasmodium Falciparum DNA Prime-Adenovirus Boost Malaria Vaccine Regimen Is Superior to a Two-antigen Regimen and Protects Against Controlled Human Malaria Infection in Healthy Malaria-naïve Adults." PloS One, vol. 16, no. 9, 2021, p. e0256980, https://doi.org/10.1371/journal.pone.0256980.